Susquehanna International Group, LLP Argenx Se Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

25 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$434.22 - $551.9 $3.99 Million - $5.08 Million	9,200 Added 11.81%	87,100 $47.2 Million
Q2 2024 Aug 15, 2024	SELL	$356.01 - $451.55 $13.4 Million - $17 Million	-37,600 Reduced 32.55%	77,900 $33.5 Million
Q1 2024 May 07, 2024	SELL	$356.95 - $413.29 $29 Million - $33.6 Million	-81,200 Reduced 41.28%	115,500 $45.5 Million
Q4 2023 Feb 14, 2024	BUY	$338.91 - $506.01 $16.4 Million - $24.5 Million	48,500 Added 32.73%	196,700 $74.8 Million
Q3 2023 Nov 14, 2023	BUY	$369.35 - $548.43 $3.36 Million - $4.99 Million	9,100 Added 6.54%	148,200 $72.9 Million
Q2 2023 Aug 11, 2023	BUY	$360.14 - $422.58 $33.8 Million - $39.7 Million	93,900 Added 207.74%	139,100 $54.2 Million
Q1 2023 May 16, 2023	SELL	$334.23 - $403.65 $11.1 Million - $13.4 Million	-33,100 Reduced 42.27%	45,200 $16.8 Million
Q4 2022 Feb 14, 2023	BUY	$342.17 - $402.31 $9.41 Million - $11.1 Million	27,500 Added 54.13%	78,300 $29.7 Million
Q3 2022 Nov 14, 2022	SELL	$343.2 - $395.75 $2.88 Million - $3.32 Million	-8,400 Reduced 14.19%	50,800 $17.9 Million
Q2 2022 Aug 15, 2022	BUY	$269.58 - $378.88 $4.26 Million - $5.99 Million	15,800 Added 36.41%	59,200 $22.4 Million
Q1 2022 May 16, 2022	SELL	$254.45 - $351.06 $2.21 Million - $3.05 Million	-8,700 Reduced 16.7%	43,400 $13.7 Million
Q4 2021 Feb 14, 2022	SELL	$272.01 - $353.03 $1.96 Million - $2.54 Million	-7,200 Reduced 12.14%	52,100 $18.2 Million
Q3 2021 Nov 15, 2021	SELL	$295.0 - $350.58 $4.48 Million - $5.33 Million	-15,200 Reduced 20.4%	59,300 $17.9 Million
Q2 2021 Aug 11, 2021	BUY	$257.11 - $319.92 $3.37 Million - $4.19 Million	13,100 Added 21.34%	74,500 $22.4 Million
Q1 2021 May 17, 2021	BUY	$268.3 - $380.31 $429,280 - $608,496	1,600 Added 2.68%	61,400 $16.9 Million
Q4 2020 Feb 16, 2021	SELL	$248.13 - $308.36 $7.94 Million - $9.87 Million	-32,000 Reduced 34.86%	59,800 $17.6 Million
Q3 2020 Nov 16, 2020	SELL	$215.51 - $272.51 $6.49 Million - $8.2 Million	-30,100 Reduced 24.69%	91,800 $24.1 Million
Q2 2020 Aug 14, 2020	SELL	$127.44 - $232.72 $8.87 Million - $16.2 Million	-69,600 Reduced 36.34%	121,900 $27.5 Million
Q1 2020 May 15, 2020	BUY	$108.83 - $165.23 $15.4 Million - $23.4 Million	141,700 Added 284.54%	191,500 $25.2 Million
Q4 2019 Feb 14, 2020	SELL	$106.59 - $164.21 $852,720 - $1.31 Million	-8,000 Reduced 13.84%	49,800 $7.99 Million
Q3 2019 Nov 14, 2019	BUY	$113.31 - $150.51 $2.45 Million - $3.25 Million	21,600 Added 59.67%	57,800 $6.59 Million
Q2 2019 Aug 14, 2019	BUY	$115.0 - $141.58 $3.46 Million - $4.26 Million	30,100 Added 493.44%	36,200 $5.13 Million
Q1 2019 May 15, 2019	SELL	$98.85 - $134.59 $563,445 - $767,163	-5,700 Reduced 48.31%	6,100 $762,000
Q4 2018 Feb 14, 2019	SELL	$63.81 - $109.82 $1.58 Million - $2.71 Million	-24,700 Reduced 67.67%	11,800 $1.13 Million
Q3 2018 Nov 14, 2018	BUY	$75.5 - $96.63 $2.76 Million - $3.53 Million	36,500 New	36,500 $2.77 Million

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

Price T Rowe Associates Inc Baltimore, MD

5.82M
Shares

$3.66 Billion
0.36% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

3.51M
Shares

$2.21 Billion
2.99% of portfolio
Janus Henderson Group PLC London, X0

2.48M
Shares

$1.56 Billion
0.72% of portfolio
Capital World Investors Los Angeles, CA

1.7M
Shares

$1.07 Billion
0.15% of portfolio
Avoro Capital Advisors LLC New York, NY

1.24M
Shares

$778 Million
10.11% of portfolio

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account